Shunsuke Kageyama

Title: Shunsuke Kageyama: Innovator in Pharmaceutical Composition

Introduction

Shunsuke Kageyama is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ulcerative colitis. With a total of six patents to his name, Kageyama's work reflects his dedication to advancing medical science.

Latest Patents

One of Kageyama's latest patents is a pharmaceutical composition for treating ulcerative colitis. This composition comprises a compound represented by a specific formula or a pharmaceutically acceptable salt thereof. The compound is administered in an amount of 600 mg or more per day to patients suffering from ulcerative colitis. Another significant patent involves a sulfonamide derivative and its medicinal use. This patent describes sulfonamide compounds with a specific chemical structure, which includes a sulfonamide group with a phenyl or heterocyclic group. These novel compounds exhibit excellent α4 integrin-inhibitory action, showcasing Kageyama's innovative approach to drug development.

Career Highlights

Throughout his career, Kageyama has worked with prominent companies in the pharmaceutical industry, including Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Kageyama has collaborated with talented individuals in his field, including Misato Noguchi and Toshihiko Sugiura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shunsuke Kageyama is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve the lives of many patients. His innovative patents and collaborations highlight his commitment to advancing medical science.